BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 28670978)

  • 21. Inhibition by nuclear cGAS.
    Otto G
    Nat Rev Mol Cell Biol; 2018 Dec; 19(12):752-753. PubMed ID: 30382173
    [No Abstract]   [Full Text] [Related]  

  • 22. Transcriptomic analysis identifies B-lymphocyte kinase as a therapeutic target for desmoplastic small round cell tumor cancer stem cell-like cells.
    Magrath JW; Flinchum DA; Hartono AB; Sampath SS; O'Grady TM; Baddoo M; Haoyang L; Xu X; Flemington EK; Lee SB
    Oncogenesis; 2024 Jan; 13(1):2. PubMed ID: 38177125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene and pathway based burden analyses in familial lymphoid cancer cases: Rare variants in immune pathway genes.
    Ralli S; Jones SJ; Leach S; Lynch HT; Brooks-Wilson AR
    PLoS One; 2023; 18(6):e0287602. PubMed ID: 37379307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The survival rate of laryngeal squamous cell carcinoma: impact of IL1RAP rs4624606, IL1RL1 rs1041973, IL-6 rs1800795, BLK rs13277113, and TIMP3 rs9621532 single nucleotide polymorphisms.
    Pasvenskaite A; Liutkeviciene R; Gedvilaite G; Vilkeviciute A; Liutkevicius V; Uloza V
    Discov Oncol; 2023 Jan; 14(1):8. PubMed ID: 36682035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma.
    Choi S; Lee YJ; Choi Y; Kim M; Kim HJ; Kim JE; Oh S; Chae SW; Cha HJ; Jo JC
    J Pathol Transl Med; 2022 Sep; 56(5):281-288. PubMed ID: 36128864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Src-family Protein Tyrosine Kinases: A promising target for treating Cardiovascular Diseases.
    Zhai Y; Yang J; Zhang J; Yang J; Li Q; Zheng T
    Int J Med Sci; 2021; 18(5):1216-1224. PubMed ID: 33526983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia.
    Creeden JF; Alganem K; Imami AS; Henkel ND; Brunicardi FC; Liu SH; Shukla R; Tomar T; Naji F; McCullumsmith RE
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting breast cancer risk using interacting genetic and demographic factors and machine learning.
    Behravan H; Hartikainen JM; Tengström M; Kosma VM; Mannermaa A
    Sci Rep; 2020 Jul; 10(1):11044. PubMed ID: 32632202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear Functions of the Tyrosine Kinase Src.
    Bagnato G; Leopizzi M; Urciuoli E; Peruzzi B
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide association studies of 74 plasma metabolites of German shepherd dogs reveal two metabolites associated with genes encoding their enzymes.
    Soh PXY; Marin Cely JM; Mortlock SA; Jara CJ; Booth R; Natera S; Roessner U; Crossett B; Cordwell S; Singh Khatkar M; Williamson P
    Metabolomics; 2019 Sep; 15(9):123. PubMed ID: 31493001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications.
    Solouki S; August A; Huang W
    Pharmacol Ther; 2019 Sep; 201():39-50. PubMed ID: 31082431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C.
    Cornish AJ; Hoang PH; Dobbins SE; Law PJ; Chubb D; Orlando G; Houlston RS
    Blood Adv; 2019 Jan; 3(1):21-32. PubMed ID: 30606723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL).
    Petersen DL; Krejsgaard T; Berthelsen J; Fredholm S; Willerslev-Olsen A; Sibbesen NA; Bonefeld CM; Andersen MH; Francavilla C; Olsen JV; Hu T; Zhang M; Wasik MA; Geisler C; Woetmann A; Odum N
    Leukemia; 2014 Oct; 28(10):2109-12. PubMed ID: 24919804
    [No Abstract]   [Full Text] [Related]  

  • 34. Dysfunctional BLK in common variable immunodeficiency perturbs B-cell proliferation and ability to elicit antigen-specific CD4+ T-cell help.
    Compeer EB; Janssen W; van Royen-Kerkhof A; van Gijn M; van Montfrans JM; Boes M
    Oncotarget; 2015 May; 6(13):10759-71. PubMed ID: 25926555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase.
    Malek SN; Dordai DI; Reim J; Dintzis H; Desiderio S
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7351-6. PubMed ID: 9636152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The p60c-src family of protein-tyrosine kinases: structure, regulation, and function.
    Brickell PM
    Crit Rev Oncog; 1992; 3(4):401-46. PubMed ID: 1384720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel BLK-induced tumor model.
    Petersen DL; Berthelsen J; Willerslev-Olsen A; Fredholm S; Dabelsteen S; Bonefeld CM; Geisler C; Woetmann A
    Tumour Biol; 2017 Jul; 39(7):1010428317714196. PubMed ID: 28670978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
    Krejsgaard T; Vetter-Kauczok CS; Woetmann A; Kneitz H; Eriksen KW; Lovato P; Zhang Q; Wasik MA; Geisler C; Ralfkiaer E; Becker JC; Ødum N
    Blood; 2009 Jun; 113(23):5896-904. PubMed ID: 19351960
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.